A Targeted Drug Delivery System for Treatment of Bone Metastasis [ 2018 - ]

Research Grant

Researchers: Dr Seyediman Roohaniesfahani (Principal investigator)

Brief description The most common site where cancer spreads is the bone. Once it happens, it can dramatically affect patient’s quality of life and chance of survival. Current treatments are mostly palliative or associate with acute side effects due to systematic administration of anticancer drugs and their inability to selectively target the diseased area. This study aims to develop a nanocarrier that can uptake, protect and deliver anticancer drugs to the affected site in bone.

Funding Amount $243,607.00

Funding Scheme Project Grants

Notes New Investigator Grant